Clarithromycin Market Regulations and Competitive Landscape Outlook to 2018-202

Posted by vakhas on January 30th, 2019

Clarithromycin belongs to class of macrolide antibiotics. Clarithromycin is an antibiotic derived from erythromycin which is used in the treatment of certain bacterial infections, including lung infection, bronchitis, and ear infections, sinuses, skin infection and infection in the throat. Its antimicrobial activity prevents the growth of bacteria. The antibiotic is used in combination with other medications to prevent H. pylori, a bacterium that causes stomach ulcers. Clarithromycin comes as a tablet and also in as suspension (liquid) form to taken orally. Clarithromycin is consumed largely over the global and was the second most consumed drug in Canada in 2014.

Clarithromycin is prescribed for number of treatments for tonsillitis and pharyngitis, bronchitis, pneumonia, Helicobacter pylori Infection. Clarithromycin drug is an antibiotic which is used against wide range of organisms like H. parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, S. pneumoniae, and S. pyogenes, Haemophilus influenzae, many anaerobic bacteria, some mycobacteria, Mycoplasma, Ureaplasma, Chlamydia, Toxoplasma, and Borrelia, C. pneumoniae and M. pneumoniae. Clarithromycin has also been popular to treat lung infection caused by Mycobacterium Avium Complex (MAC) in HIV carriers. 

Request For Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2869

Global Clarithromycin Market: Drivers and Restraints

Clarithromycin can be taken by all age groups - adults and children and hence the global market for Clarithromycin is wide. Clarithromycin is a generic drug used fight bacteria affecting skin and respiratory infections making the global Clarithromycin market even vaster. Clarithromycin is particularly popular in individuals possessing penicillin allergy.

However, clarithromycin is ineffective during cold, flu or other viral infection. Clarithromycin is recommended to not consume clarithromycin by patients who are allergic to chemically-related macrolide antibiotics or certain antibiotics, such as erythromycin. Clarithromycin may be taken by adult in dose 250-500 mg of immediate release tablets after meal twice daily. 

Global Clarithromycin Market: Overview

Clarithromycin is majorly used in treatment of ulcers caused by H. pylori which largely affect the population worldwide. Ninety percent of ulcers are caused by H. pylori and approximately 500,000 – 850,000 new cases of ulcer disease are registered each year affected all age groups according to CDC. As there is no vaccine available, the global market for clarithromycin is estimated to foresee expansion.